La Jolla, California
United States
201
2025-10-23
The entities that hold a legal rights for patent applications filed by inventor Schultz Peter G.:
Peter G. Schultz from La Jolla, US has applied for patents for these inventions. The list has both pending applications and granted patents:
LONG-ACTING DUAL GIP/GLP-1 PEPTIDE CONJUGATES AND METHODS OF USE
#2 | 2025-10-16LONG-ACTING DUAL GIP/GLP-1 PEPTIDE CONJUGATES AND METHODS OF USE
#3 | 2025-07-24MODIFIED THERAPEUTIC AGENTS AND COMPOSITIONS THEREOF
#4 | 2025-06-26SMALL MOLECULE INHIBITORS OF TEA DOMAIN FAMILY MEMBERS
#5 | 2025-04-24PHARMACOLOGICAL DEPLETION OF HEME FOR THE TREATMENT OF MYELODYSPLASTIC SYNDROME
#6 | 2024-05-30SMALL MOLECULE REGULATORS OF ALVEOLAR TYPE 2 CELL PROLIFERATION FOR THE TREATMENT OF PULMONARY DISEASES
#7 | 2024-05-09LONG-ACTING DUAL GIP/GLP-1 PEPTIDE CONJUGATES AND METHODS OF USE
#8 | 2024-05-09SMALL MOLECULE ACTIVATORS OF YAP TRANSCRIPTIONAL ACTIVITY FOR REGENERATIVE ORGAN REPAIR
#9 | 2024-04-11SMALL MOLECULE REGULATORS OF ALVEOLAR TYPE 2 CELL PROLIFERATION FOR THE TREATMENT OF PULMONARY DISEASES
#10 | 2023-11-09AGONISTS OF STIMULATOR OF INTERFERON GENES STING
#11 | 2023-11-09PEPTIDIC CHIMERIC ANTIGEN RECEPTOR T CELL SWITCHES AND USES THEREOF
#12 | 2023-11-02METHODS AND COMPOSITIONS FOR THE TREATMENT OF SARS-COV-2
#13 | 2023-11-02Small molecule inhibitors of cancer stem cells and mesenchymal cancer types
#14 | 2023-06-22Humanized anti-CD3 antibodies, conjugates and uses thereof
#15 | 2023-04-13ANTIMALARIAL COMPOSITIONS AND USES THEREOF
#16 | 2023-03-09PEPTIDE CONJUGATES AND METHODS OF USE
#17 | 2023-02-23GLP2 RECEPTOR AGONISTS AND METHODS OF USE
#18 | 2022-12-15TARGETING AGENT ANTIBODY CONJUGATES AND USES THEREOF
#19 | 2022-10-20BICYCLIC AGONISTS OF STIMULATOR OF INTERFERON GENES STING
#20 | 2022-09-15MONOCYCLIC AGONISTS OF STIMULATOR OF INTERFERON GENES STING
#21 | 2022-03-10Chimeric antigen receptor effector cell switches with humanized targeting moieties and/or optimized chimeric antigen receptor interacting domains and uses thereof
#22 | 2022-03-10MODIFIED THERAPEUTIC AGENTS AND COMPOSITIONS THEREOF
#23 | 2022-02-17Relaxin immunoglobulin fusion proteins and methods of use
#24 | 2022-01-06Modified therapeutic agents, stapled peptide lipid conjugates, and compositions thereof
#25 | 2021-11-25METHODS FOR INDUCING CHONDROGENESIS
#26 | 2021-07-08Agonists of stimulator of interferon genes sting
#27 | 2021-07-01Small molecule inhibitors of cancer stem cells and mesenchymal cancer types
#28 | 2021-06-24COMPOUNDS THAT EXPAND HEMATOPOIETIC STEM CELLS
#29 | 2021-06-17Antimalarial compositions and uses thereof
#30 | 2021-03-04Composition and methods for inhibiting mammalian sterile 20-like kinase 1
#31 | 2020-08-27Coiled coil immunoglobulin fusion proteins and compositions thereof
#32 | 2020-06-25PEPTIDIC CHIMERIC ANTIGEN RECEPTOR T CELL SWITCHES AND USES THEREOF
#33 | 2020-06-18Compounds and methods for inducing chondrogenesis
#34 | 2020-04-16Insulin immunoglobulin fusion proteins
#35 | 2020-02-27METHODS AND COMPOSITIONS FOR PREVENTING VECTOR-BORNE DISEASE TRANSMISSION
#36 | 2019-11-28Chimeric antigen receptor effector cell switches with humanized targeting moieties and/or optimized chimeric antigen receptor interacting domains and uses thereof
#37 | 2019-10-31Modified therapeutic agents and compositions thereof
#38 | 2019-10-17Targeting agent antibody conjugates and uses thereof
#39 | 2019-08-29Relaxin immunoglobulin fusion proteins and methods of use
#40 | 2019-07-04Antimalarial compositions and uses thereof
#41 | 2019-06-06Optimized PNE-based chimeric receptor T cell switches and uses thereof
#42 | 2019-01-24Insulin immunoglobulin fusion proteins
#43 | 2019-01-03MODIFIED THERAPEUTIC AGENTS AND COMPOSITIONS THEREOF
#44 | 2018-12-20Composition and methods for inhibiting mammalian sterile 20-like kinase 1
#45 | 2018-12-06Modified therapeutic agents, stapled peptide lipid conjugates, and compositions thereof
#46 | 2018-09-27METHODS FOR TREATING VIRAL INFECTIONS
#47 | 2018-07-26MODIFIED THERAPEUTIC AGENTS AND COMPOSITIONS THEREOF
#48 | 2018-05-03Switchable non-scFv chimeric receptors, switches, and methods of use thereof to treat cancer
#49 | 2018-04-19CHIMERIC ANTIGEN RECEPTOR T CELL SWITCHES AND USES THEREOF
#50 | 2018-04-12OPTIMIZED CHIMERIC RECEPTOR T CELL SWITCHES AND USES THEREOF
#51 | 2017-12-21Small molecule inhibitors of fibrosis
#52 | 2017-11-16METHODS OF CONSTRUCTING AMINO TERMINAL IMMUNOGLOBULIN FUSION PROTEINS AND COMPOSITIONS THEREOF
#53 | 2017-08-31Peptidic chimeric antigen receptor T cell switches and uses thereof
#54 | 2017-08-24COMPOUNDS THAT EXPAND HEMATOPOIETIC STEM CELLS
#55 | 2017-08-03Small molecule inhibitors of fibrosis
#56 | 2017-07-27CONSTANT REGION ANTIBODY FUSION PROTEINS AND COMPOSITIONS THEREOF
#57 | 2017-05-25ELASTASE INHIBITORS
#58 | 2017-01-19AURISTATIN-ANTIBODY CONJUGATES AND USES THEREOF
#59 | 2017-01-05TARGETING AGENT ANTIBODY CONJUGATES AND USES THEREOF
#60 | 2016-11-10LIVER X RECEPTOR AGONISTS AND USES THEREOF
#61 | 2016-11-03Modified therapeutic agents, stapled peptide lipid conjugates, and compositions thereof
#62 | 2016-10-06Modified therapeutic agents and compositions thereof
#63 | 2016-08-18IMMUNOGLOBULIN FUSION PROTEINS AND COMPOSITIONS THEREOF
#64 | 2016-07-07COMPOUNDS FOR TREATMENT OF DRUG RESISTANT AND PERSISTENT TUBERCULOSIS
#65 | 2016-06-09Coiled coil immunoglobulin fusion proteins and compositions thereof
#66 | 2016-06-09Compounds for treatment of cystic fibrosis
#67 | 2016-05-12Small molecule inhibitors of fibrosis
#68 | 2016-04-28Targeting agent antibody conjugates and uses thereof
#69 | 2016-02-18Compounds and methods for inducing chondrogenesis
#70 | 2016-01-21BISPECIFIC ANTIBODIES AND USES THEREOF
#71 | 2015-12-31Bovine fusion antibodies
#72 | 2015-10-29Peptidic chimeric antigen receptor T cell switches and uses thereof
#73 | 2015-08-27Expanding the eukaryotic genetic code
#74 | 2015-08-27CHIMERIC ANTIGEN RECEPTOR T CELL SWITCHES AND USES THEREOF
#75 | 2015-01-15Unnatural reactive amino acid genetic code additions
#76 | 2014-09-25In vivo unnatural amino acid expression in the methylotrophic yeast
#77 | 2014-09-18Compounds and methods for inducing chondrogenesis
#78 | 2014-08-14Bovine fusion antibodies
#79 | 2014-06-19Production of carrier-peptide conjugates using chemically reactive unnatural amino acids
#80 | 2014-04-24Compounds that expand hematopoietic stem cells
#81 | 2013-11-21Methods and compositions for the production of orthogonal tRNA-aminoacyl tRNA synthetase pairs
#82 | 2013-09-19Unnatural reactive amino acid genetic code additions
#83 | 2013-09-19Orthogonal translation components for the in vivo incorporation of unnatural amino acids
#84 | 2013-08-01Compositions and methods for inducing cell dedifferentiation
#85 | 2012-12-27GENETICALLY ENCODED FLUORESCENT COUMARIN AMINO ACIDS
#86 | 2012-11-08Expanding the eukaryotic genetic code
#87 | 2012-11-08Genetically programmed expression of proteins containing the unnatural amino acid phenylselenocysteine
#88 | 2012-11-08Selective incorporation of 5-hydroxytryptophan into proteins in mammalian cells
#89 | 2012-10-04Expanding the eukaryotic genetic code
#90 | 2012-10-04Systems for the expression of orthogonal translation components in eubacterial host cells
#91 | 2012-08-09IN Vivo Incorporation of Unnatural Amino Acids
#92 | 2012-07-19Genetically programmed expression of selectively sulfated proteins in Eubacteria
#93 | 2012-07-12Mesenchymal stem cell differentiation
#94 | 2012-06-21Compositions and methods for inducing neuronal differentiation
#95 | 2012-05-24Compositions of orthogonal lysyl-tRNA and aminoacyl-tRNA synthetase pairs and uses thereof
#96 | 2012-04-26Methods and Compositions for the Production of Orthogonal tRNA-Aminoacyl tRNA Synthetase Pairs
#97 | 2012-04-26Site-specific incorporation of redox active amino acids into proteins
#98 | 2012-01-05Unnatural reactive amino acid genetic code additions
#99 | 2011-12-29Site specific incorporation of keto amino acids into proteins
#100 | 2011-12-22Production of carrier-peptide conjugates using chemically reactive unnatural amino acids
366958 ⎘